{"id":"CHEMBL1094","canonicalSmiles":"NC(=O)OCC(COC(N)=O)c1ccccc1","inchiKey":"WKGXYQFOCVYPAC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FELBAMATE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Felbamate","Felbatol","Taloxa"],"synonyms":["ADD-03055","Felbamate","NSC-759866","W-554"],"crossReferences":{"DailyMed":["felbamate"],"PubChem":["104171154","11113343","144203696","144212685","170465178","50104096","56422162","855835","90340922"],"Wikipedia":["Felbamate"],"drugbank":["DB00949"],"chEBI":["4995"]},"childChemblIds":["CHEMBL2130858"],"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000116032","ENSG00000161509","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["EFO_0000474","EFO_0000289","MONDO_0002280","HP_0001250"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1163074","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COS(=O)(=O)NC(=O)[C@@H](N)CS)[C@@H](O)[C@H]1O","inchiKey":"FTSDEWPMACCNGN-YTMOPEAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1163074","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02684"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1183605","canonicalSmiles":"CCCCCCCCCCCCCCCC[N+](C)(C)C","inchiKey":"RLGQACBPNDBWTB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETRIMONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cetrimonium","Cetrimonium cation","Cetrimonium ion","Cetyltrimethylammonium cation","Cetyltrimethylammonium ion","Hexadecyltrimethylammonium ion","PB-300"],"crossReferences":{"drugbank":["DB01718"],"chEBI":["39561"]},"childChemblIds":["CHEMBL1600855","CHEMBL307346","CHEMBL1895807"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200480","canonicalSmiles":"CC(=O)O.C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O","inchiKey":"XQEJFZYLWPSJOV-XJQYZYIXSA-N","drugType":"Protein","blackBoxWarning":false,"name":"OCTREOTIDE ACETATE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1680","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bynfezia pen","Mycapssa","Octreotide acetate","Octreotide acetate (preservative free)","Octreotide acetate preservative free","Sandostatin","Sandostatin lar"],"synonyms":["Octreolin","Octreotide (as acetate)","Octreotide acetate","SMS 201-995 AC","SMS-201-995 AC","SMS-201995-AC"],"crossReferences":{"DailyMed":["octreotide%20acetate"]},"linkedTargets":{"rows":["ENSG00000162009","ENSG00000278195","ENSG00000132671","ENSG00000139874","ENSG00000180616"],"count":5},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0043579","HP_0002014","EFO_1001901","MONDO_0007254","Orphanet_657","EFO_0003770","EFO_0004243","EFO_0001073","EFO_1002048","MONDO_0004565","MONDO_0008315","EFO_0009708","MONDO_0002691","EFO_1000097","Orphanet_739","EFO_1001485","MONDO_0002120","EFO_0000574","EFO_1000852","EFO_0002626","MONDO_0024880","HP_0002019","MONDO_0017611"],"count":24},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and has 4 approved and 17 investigational indications."}
{"id":"CHEMBL1200829","canonicalSmiles":"O=C1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"PHOQVHQSTUBQQK-SQOUGZDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUCONOLACTONE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[".delta.-d-gluconolactone","D-gluconic acid .delta.-lactone","D-gluconic acid delta-lactone","D-glucono-1,5-lactone","Delta-gluconolactone","E-575","E575","Fujiglucon","Glucono .delta. lactone","Glucono .delta.-lactone","Glucono delta-lactone","Glucono-delta-lactone","Gluconolactone","INS NO.575","INS-575","Lysactone","NSC-34393","NSC-758238","Riken lactone"],"crossReferences":{"DailyMed":["gluconolactone"],"PubChem":["144204936","144207627","170465327","26748700"],"Wikipedia":["Glucono_delta-lactone"],"drugbank":["DB04564"],"chEBI":["16217"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990."}
{"id":"CHEMBL1200870","canonicalSmiles":"CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1.O=C(O)/C=C\\C(=O)O","inchiKey":"WLRMANUAADYWEA-NWASOUNVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIMOLOL MALEATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL499","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Blocadren","Istalol","Timolol maleate","Timoptic","Timoptic Xe","Timoptic in ocudose","Timoptic-xe"],"synonyms":["Aquanil","NSC-757351","Ophtamolol","Timolol (as maleate)","Timolol hydrogen maleate salt","Timolol maleate","Timolol maleate, s-enantiomer","Timololi maleas","WP-934"],"crossReferences":{"DailyMed":["timolol%20maleate"],"PubChem":["144212785","56423148","855659","93576681"],"chEBI":["9600"]},"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069","EFO_1000879","EFO_1000809","EFO_0000516","EFO_0000666","EFO_1000635"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 3 approved and 4 investigational indications."}
{"id":"CHEMBL1200937","canonicalSmiles":"CCN(CC)CCS(=O)(=O)[C@@H]1CCN2C(=O)c3coc(n3)CC(=O)C[C@H](O)/C=C(C)/C=C/CNC(=O)/C=C/[C@@H](C)[C@@H](C(C)C)OC(=O)[C@@H]12","inchiKey":"SUYRLXYYZQTJHF-VMBLUXKRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DALFOPRISTIN","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dalfopristin","RP 54476","RP-54476"],"crossReferences":{"DailyMed":["dalfopristin"],"Wikipedia":["Dalfopristin"],"drugbank":["DB01764"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1999 and has 1 investigational indication."}
{"id":"CHEMBL1200943","drugType":"Small molecule","blackBoxWarning":false,"name":"MERSALYL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Salyrgan"],"synonyms":["Mercuramide","Mersalyl","Mersalyl sodium"],"crossReferences":{"DrugCentral":["4657"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1201728","canonicalSmiles":"CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1.O=C(O)CCC(=O)O","inchiKey":"ORUUBRMVQCKYHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DESVENLAFAXINE SUCCINATE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1118","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Desvenlafaxine succinate","Pristiq"],"synonyms":["DVS-233","Desvenlafaxine succinate","Desvenlafaxine succinate anhydrous","Desvenlafaxine succinate hydrate","Desvenlafaxine succinate monohydrate","Dvs anhydrous","O-desmethylvenlafaxine succinate","WY-45233","WY45233"],"crossReferences":{"DailyMed":["desvenlafaxine%20succinate"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_1000783","EFO_0005687","MONDO_0002050","MONDO_0002009","EFO_0003761","HP_0031217","EFO_1001917","EFO_0003922"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for unipolar depression and major depressive disorder and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201748","canonicalSmiles":"CO[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C(C)=C([C@@H](OC)C(=O)[C@]12C)C3(C)C","inchiKey":"BMQGVNUXMIRLCK-OAGWZNDDSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CABAZITAXEL","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Jevtana","Jevtana kit"],"synonyms":["Cabazitaxel","Cabazitaxel acetonate","Jevtana","NSC-761432","TXD 258","TXD-258","XRP 6258","XRP-6258"],"crossReferences":{"Wikipedia":["Cabazitaxel"],"drugbank":["DB06772"],"chEBI":["63584"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["MONDO_0003890","MONDO_0007254","EFO_0003085","EFO_1001951","MONDO_0001056","MONDO_0001657","EFO_0000673","EFO_0008528","EFO_0000196","EFO_0000326","EFO_1001094","EFO_0000616","MONDO_0021656","EFO_0005088","EFO_0006859","EFO_1000601","MONDO_0008170","MONDO_0004986","MONDO_0008315","EFO_0003060","EFO_0001663","EFO_0000311","EFO_0000702","EFO_0006544","EFO_1000796","MONDO_0024880","EFO_0000181","EFO_0000519"],"count":28},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 6 approved and 18 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1222313","canonicalSmiles":"O=C(O)c1ccc(NS(=O)(=O)c2ccsc2C(=O)O)c(O)c1","inchiKey":"RDPXXOOKKRIKFN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1222313","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07927"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229801","canonicalSmiles":"CC(C)C[C@@H](N)C(=O)N1CCC[C@H]1C(=O)NCc1cccc(Cl)c1","inchiKey":"FHVBVJXZKNCSLP-CVEARBPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229801","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06911"]},"childChemblIds":["CHEMBL3422995"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230906","canonicalSmiles":"CC(C)(N)C(=O)O","inchiKey":"FUOOLUPWFVMBKG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Alpha-Aminoisobutyric Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alpha-Aminoisobutyric Acid"],"crossReferences":{"drugbank":["DB02952"],"chEBI":["27971"]},"childChemblIds":["CHEMBL1770613"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234669","canonicalSmiles":"CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"OVRNDRQMDRJTHS-PVFLNQBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234669","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03740"],"chEBI":["44278"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234674","canonicalSmiles":"CC[N+](C)(C)CCCS(=O)(=O)[O-]","inchiKey":"NNCRHRDBFDCWPA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYL DIMETHYL AMMONIO PROPANE SULFONATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02618"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234815","canonicalSmiles":"Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21","inchiKey":"UOKGZPYGRJDACN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234815","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08300"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235782","canonicalSmiles":"CO[C@H]1CCCC[C@@H](c2ccccc2)OC(=O)[C@@H](C)[C@@]2(O)O[C@@H]([C@@H](C)/C=C/[C@H]1OC)[C@@H](C)[C@H](O)[C@H]2OC","inchiKey":"WPMGNXPRKGXGBO-OFQQMTDKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SORAPHEN A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02859"],"chEBI":["9200"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237061","canonicalSmiles":"O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Ca+2]","inchiKey":"RHGYHLPFVJEAOC-FFNUKLMVSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PITAVASTATIN CALCIUM","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201753","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Livalo","Pitavastatin calcium"],"synonyms":["Itavastatin calcium","NK-104","Pitavastatin Calcium","Pitavastatin calcium","Pitavastatin calcium salt"],"crossReferences":{"DailyMed":["pitavastatin%20calcium"],"PubChem":["49681579"],"chEBI":["71258"]},"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["HP_0003124","MONDO_0021187","HP_0003119","Orphanet_309005"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for abnormal circulating lipid concentration and hyperlipidemia and has 2 investigational indications."}
{"id":"CHEMBL128136","canonicalSmiles":"C[S@@+]([O-])CCCCN=C=S","inchiKey":"SUVMJBTUFCVSAD-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL128136","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217652"],"drugbank":["DB12422"],"chEBI":["47808"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1296","canonicalSmiles":"CN(C)CCn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3csc(N)n3)[C@H]2SC1","inchiKey":"QYQDKDWGWDOFFU-IUODEOHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOTIAM","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aspil","Cefotiam","Ceradon","J01DC07"],"crossReferences":{"Wikipedia":["Cefotiam"],"drugbank":["DB00229"],"chEBI":["355510"]},"childChemblIds":["CHEMBL4303232","CHEMBL1200589"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988 and is indicated for bacterial disease."}
{"id":"CHEMBL1321154","canonicalSmiles":"O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O","inchiKey":"XMVJITFPVVRMHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROXARSONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11112265","124882145","144203953","144208663","144213159","170465666","26748242","56463154"],"drugbank":["DB11458"],"chEBI":["35817"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1322675","canonicalSmiles":"CCCNC[C@H](O)COc1ccccc1C(=O)CCc1ccccc1","inchiKey":"JWHAUXFOSRPERK-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1322675","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111634","11111635","11112738","50100315","50111221"],"drugbank":["DB15410"]},"childChemblIds":["CHEMBL1256654"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1325863","canonicalSmiles":"CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@H](Cn1c2nc(=O)[nH]c(=O)c-2nc2cc(C)c(C)cc21)OC(=O)CCC","inchiKey":"MJNIWUJSIGSWKK-BBANNHEPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1325863","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206329","50125897"],"drugbank":["DB14727"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1374069","canonicalSmiles":"OC1OC[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"SRBFZHDQGSBBOR-CZBDKTQLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1374069","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217854"],"drugbank":["DB03911"],"chEBI":["59275"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL143324","canonicalSmiles":"CS(=N)(=O)CC[C@H](N)C(=O)O","inchiKey":"SXTAYKAGBXMACB-DPVSGNNYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL143324","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50106626"],"drugbank":["DB14103"],"chEBI":["28490"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1493","canonicalSmiles":"Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O","inchiKey":"SPIUTQOUKAMGCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLAVOXATE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bladuril","Flavoxate"],"crossReferences":{"DailyMed":["flavoxate%20hydrochloride"],"PubChem":["11112543"],"Wikipedia":["Flavoxate"],"drugbank":["DB01148"],"chEBI":["5088"]},"childChemblIds":["CHEMBL1200875"],"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000171408","ENSG00000205268","ENSG00000113231","ENSG00000073417","ENSG00000184588"],"count":8},"linkedDiseases":{"rows":["EFO_0003103","EFO_0003901","HP_0000020","EFO_0003830","EFO_0003843","EFO_0003878","HP_0000103"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and has 6 approved indications."}
{"id":"CHEMBL1508","canonicalSmiles":"CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21","inchiKey":"WSEQXVZVJXJVFP-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESCITALOPRAM","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cipralex"],"synonyms":["Escitalopram","Esertia","Esitol","LU-26-054"],"crossReferences":{"DailyMed":["escitalopram%20oxalate"],"PubChem":["11110983","11114081","124879737","50100207"],"Wikipedia":["Escitalopram"],"drugbank":["DB01175"],"chEBI":["36791"]},"childChemblIds":["CHEMBL1200322"],"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0005687","EFO_0004262","EFO_0002610","MONDO_0002009","MONDO_0004169","EFO_0000555","HP_0000726","EFO_0007453","EFO_1001919","EFO_0008568","EFO_1001917","EFO_0004698","MONDO_0002046","HP_0100543","EFO_0000289","MONDO_0002050","EFO_1001375","EFO_0000712","EFO_0003884","EFO_0003761","MONDO_0001162","EFO_0003047","EFO_0004242","MONDO_0007079","EFO_0005230","MONDO_0005149","EFO_0006788","HP_0012076","EFO_0001645","EFO_1001908","EFO_0009963","EFO_0000313","EFO_0001358","HP_0002381","EFO_0009867","EFO_0003843","EFO_0000660","EFO_0000311","EFO_1001892","EFO_0003890","EFO_0008623","EFO_0010282","MONDO_0002491","EFO_0002517","MONDO_0004975","EFO_1000781","EFO_0005411"],"count":48},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 5 approved and 28 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1517","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12","inchiKey":"IWVCMVBTMGNXQD-PXOLEDIWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYTETRACYCLINE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Berkmycen","Chemocycline","Galenomycin","Hi-Tet","Imperacin","Microtet","OXTC","Oxymycin","Oxytetramix-250","Terramycin","Tetraplex","Unimycin"],"synonyms":["5-hydroxytetracycline dihydrate","E703","NSC-757262","NSC-9169","Nitox","Oxitetracycline","Oxytetracycline","Oxytetracycline (anhydrous)","Oxytetracycline anhydrous","Oxytetracycline dehydrate","Oxytetracycline dihydrate","Oxytetracyclinum dihydras","Terrafungine","Terramycine"],"crossReferences":{"PubChem":["144212697"],"Wikipedia":["Oxytetracycline"],"drugbank":["DB00595"],"chEBI":["27701"]},"childChemblIds":["CHEMBL3989568","CHEMBL1892210","CHEMBL1607480"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for eye infection and bacterial disease and has 2 investigational indications."}
{"id":"CHEMBL152","canonicalSmiles":"Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1","inchiKey":"VWFCHDSQECPREK-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CIDOFOVIR","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cidofovir","Vistide"],"synonyms":["Anhydrous cidofovir","Cidofovir","Cidofovir anhydrous","Cidofovir dihydrate","GS-0504","Hpmpc","Hpmpc dihydrate","NSC-742135","Vistide"],"crossReferences":{"DailyMed":["cidofovir"],"PubChem":["144206546"],"Wikipedia":["Cidofovir"],"drugbank":["DB00369"],"chEBI":["3696"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 3 approved and 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1569","canonicalSmiles":"Cl.NC12CC3CC(CC(C3)C1)C2","inchiKey":"WOLHOYHSEKDWQH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMANTADINE HYDROCHLORIDE","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL660","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amantadine hydrochloride","Gocovri","Lysovir","Mantadine","Osmolex er","Symadine","Symmetrel"],"synonyms":["Adamantanamine hydrochloride","Amantadine hcl","Amantadine hydrochloride","EXP-105-1","Mantadix","NSC-83653","Osmolex"],"crossReferences":{"DailyMed":["amantadine%20hydrochloride"],"PubChem":["26747411","26747412","50105719","50105720"],"chEBI":["2619"]},"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000116032","ENSG00000161509","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0004247","EFO_1001175","MONDO_0100096","EFO_0000544","MONDO_0005301","HP_0001300","MONDO_0005180","EFO_1001402","EFO_1000632","EFO_0007328","MONDO_0043510","EFO_0003047","EFO_0005411","EFO_1000860"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and has 7 approved and 7 investigational indications."}
{"id":"CHEMBL15770","canonicalSmiles":"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\\c1ccc([S+](C)[O-])cc1","inchiKey":"MLKXDPUZXIRXEP-MFOYZWKCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SULINDAC","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clinoril","Sulindac"],"synonyms":["Arthrocine","Artribid","MK-231","NSC-757344","Sulindac"],"crossReferences":{"DailyMed":["sulindac"],"PubChem":["11111823","11111824","11114189","124881496","144203821","144211735","170464648","26732639","50106970","85231236","90341400"],"TG-GATEs":["100"],"Wikipedia":["Sulindac"],"drugbank":["DB00605"],"chEBI":["9352"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0000685","EFO_0009907","MONDO_0007254","EFO_0000222","EFO_0005755","Orphanet_908","EFO_1001951","MONDO_0003937","Orphanet_733","EFO_0000389","MONDO_0021074","EFO_0004142","MONDO_0005178","EFO_0000181"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 4 approved and 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1587228","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(Cl)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO","inchiKey":"GGXMRPUKBWXVHE-MIHLVHIWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOMETASONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Halometasone"],"crossReferences":{"PubChem":["26719837"],"drugbank":["DB13728"]},"childChemblIds":["CHEMBL2360244"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL159226","canonicalSmiles":"CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C","inchiKey":"VRYMTAVOXVTQEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOXISYLYTE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Hepatotoxicity"],"year":1993},"tradeNames":["Erecnos","Moxivig"],"synonyms":["Acetoxythymoxamine","Carlytene","Moxisylyte","Moxisylyte hcl","Moxisylyte hydrochloride","NSC-170448","Thymoxamine","Thymoxamine hcl","Thymoxamine hydrochloride"],"crossReferences":{"PubChem":["11111464","11111465","90340735"],"TG-GATEs":["61"],"drugbank":["DB09205"]},"childChemblIds":["CHEMBL1256739"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["EFO_0004234","EFO_0000319"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for erectile dysfunction and cardiovascular disease. It was withdrawn in France  in 1993 due to Hepatotoxicity."}
{"id":"CHEMBL1605","canonicalSmiles":"Nc1nc(/C(=C/CC(=O)O)C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=CCS[C@H]23)cs1","inchiKey":"UNJFKXSSGBWRBZ-BJCIPQKHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTIBUTEN","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cedax","Seftem"],"synonyms":["7432-S","ACHN-383","ACHN383","Ceftibuten","Ceftibuten dihydrate","Ceftibuten hydrate","Ceftibutin","NSC-758925","SCH 39720","SCH-39720"],"crossReferences":{"DailyMed":["ceftibuten%20dihydrate"],"PubChem":["144204999"],"Wikipedia":["Ceftibuten"],"drugbank":["DB01415"],"chEBI":["3510"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL1688243","canonicalSmiles":"CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C","inchiKey":"ZMCJFJZOSKEMOM-DNKZPPIMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INCB-9471","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INCB-009471","INCB009471","INCB9471","Incb-9471"],"crossReferences":{"drugbank":["DB12960"]},"linkedTargets":{"rows":["ENSG00000160791"],"count":1},"linkedDiseases":{"rows":["EFO_0000764"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1698","canonicalSmiles":"CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1.Cl","inchiKey":"HEYVINCGKDONRU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUPROPION HYDROCHLORIDE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL894","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bupropion hydrochloride","Forfivo xl","Wellbutrin","Wellbutrin 100","Wellbutrin 75","Wellbutrin sr","Wellbutrin xl","Zyban"],"synonyms":["Amfebutamone hydrochloride","BW 323","BW-323","Bupropion HCl","Bupropion hcl","Bupropion hydrochloride","Mysimba","NSC-315851"],"crossReferences":{"DailyMed":["bupropion%20hydrochloride"],"PubChem":["144204172","144212161","170464747","26747451","49681824","50105906","573995","855813"]},"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0004319","EFO_0005203","MONDO_0002009","Orphanet_905","EFO_0003768","EFO_0009963","EFO_0000313","EFO_0001073","EFO_0004318","EFO_0004247","EFO_0000289","MONDO_0002050","MONDO_0002491","MONDO_0008903","EFO_0003761","MONDO_0007079"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 4 approved and 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1743016","drugType":"Antibody","blackBoxWarning":false,"name":"FARLETUZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Farletuzumab","M3","MORAb-003"],"linkedTargets":{"rows":["ENSG00000110195"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0002158","EFO_1001100","EFO_0000571","MONDO_0008170","EFO_0008516"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1743260","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CC[Si](C)(C)C)cccc3nc2-1","inchiKey":"SYXGVIWFCCQOEK-VWLOTQADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KARENITECIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Karenitecin"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1808388","canonicalSmiles":"OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(OCCOC4CC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"BTCRKOKVYTVOLU-SJSRKZJXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEXAGLIFLOZIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bexagliflozin","EGT-0001442","EGT-1442","EGT0001442","EGT1442","THR-1442","THR1442"],"crossReferences":{"drugbank":["DB12236"]},"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["MONDO_0001134","MONDO_0005148","EFO_0000400"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1817709","canonicalSmiles":"CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCC(N)=O)NC1=O","inchiKey":"JCVQBJTWWDYUFQ-MRUTUVJXSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SELEPRESSIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FE 202158","FE-202158","FE202158","Fe-202158","Selepressin"],"crossReferences":{"drugbank":["DB12495"]},"linkedTargets":{"rows":["ENSG00000166148"],"count":1},"linkedDiseases":{"rows":["EFO_0006834"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1868702","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21CC","inchiKey":"BJJXHLWLUDYTGC-ANULTFPQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GESTRINONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dimetriose"],"synonyms":["A 46 745","A-46-745","A-46745","Gestrinone","R 2323","R-2323","RU 2323","RU-2323"],"crossReferences":{"PubChem":["144206014","170466364","50112711"],"drugbank":["DB11619"],"chEBI":["89642"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL197","canonicalSmiles":"COc1ccc(CCN(C)CCC[C@](C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC","inchiKey":"SGTNSNPWRIOYBX-HHHXNRCGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXVERAPAMIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(r)-verapamil","D-verapamil","Dexverapamil","Verapamil (r)-form","Verapamil, (r)-"],"crossReferences":{"PubChem":["26751824","26755233","50104517"],"drugbank":["DB14063"],"chEBI":["77734"]},"childChemblIds":["CHEMBL1994739","CHEMBL570489"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL208375","canonicalSmiles":"C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCCCCCCCCCc1ccc(I)cc1","inchiKey":"ZOAIEFWMQLYMTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NM-404","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["18-(P-Iodophenyl)Octadecylphosphocholine","CLR-1401","NM404","Nm-404","Nm404"],"childChemblIds":["CHEMBL4297390","CHEMBL380628","CHEMBL4297495"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2096650","canonicalSmiles":"O.O.O.O.O.O=S([O-])([O-])=S.[Na+].[Na+]","inchiKey":"PODWXQQNRWNDGD-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM THIOSULFATE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1208642","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ametox","Sodium thiosulfate","Sodothiol","Sulfothiorine"],"synonyms":["DB-020","Db-020","E-539","E539","Ins no.539","Ins-539","NSC-45624","Natrii thiosulfas","Sodium hyposulfite","Sodium thiosulfate","Sodium thiosulfate anhydrous","Sodium thiosulfate hydrate","Sodium thiosulfate pentahydrate","Sodium thiosulfate, anhydrous","Sodium thiosulphate anhydrous","Sodium thiosulphate, anhydrous","Thiosulfuric acid, disodium salt"],"crossReferences":{"DailyMed":["sodium%20thiosulfate"],"DrugCentral":["4518"],"chEBI":["32150"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 12 investigational indications."}
{"id":"CHEMBL2103751","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCCc1ccc(N(CCCl)CCCl)cc1","inchiKey":"HFVNWDWLWUCIHC-GUPDPFMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREDNIMUSTINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LEO-1031","NSC-134087","NSC-171345","Prednimustine","Prednisolone chlorambucil ester","Sterecyt","Stereocyt"],"crossReferences":{"drugbank":["DB12832"],"chEBI":["82524"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105555","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)[C@@H]1c1cccc([N+](=O)[O-])c1","inchiKey":"QZVNQOLPLYWLHQ-ZEQKJWHPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENIDIPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB09231"]},"childChemblIds":["CHEMBL2359165"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105581","canonicalSmiles":"C=CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)cc(OC)c1OC","inchiKey":"RYJXBGGBZJGVQF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERALIPRIDE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Spain"],"classes":["Dermatological toxicity"," Neurotoxicity"," Psychiatric toxicity"],"year":2005},"tradeNames":["Agreal"],"synonyms":["Agradil","Veralipride"],"crossReferences":{"PubChem":["144205502"],"drugbank":["DB13523"]},"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["EFO_0005407"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979 and is indicated for psychosis. It was withdrawn in Spain  in 2005 due to Dermatological toxicity,  Neurotoxicity and  Psychiatric toxicity."}
{"id":"CHEMBL2105631","canonicalSmiles":"CC[C@H](C)OC(=O)Cc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1","inchiKey":"ZXOSVKYCXLTVGS-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUDIODARONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATI-2042","Budiodarone"],"crossReferences":{"drugbank":["DB05519"]},"childChemblIds":["CHEMBL2105632"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106403","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@](C)(F)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O","inchiKey":"XOEUHCONYHZURQ-HNUBZJOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLURITHROMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(8s)-8-fluoroerythromycin","Flurithromycin"],"crossReferences":{"drugbank":["DB13338"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107387","canonicalSmiles":"Br.Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1","inchiKey":"VNGRUFUIHGGOOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VORTIOXETINE HYDROBROMIDE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2104993","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Trintellix"],"synonyms":["Lu AA21004 (HBr)","Lu aa21004 hbr","Lu-aa21004 hydrobromide","Vortioxetine hydrobromide"],"crossReferences":{"DailyMed":["vortioxetine%20hydrobromide"],"chEBI":["76015"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000178394","ENSG00000166736"],"count":3},"linkedDiseases":{"rows":["MONDO_0002009","EFO_0003761"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for major depressive disorder and unipolar depression. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2107771","canonicalSmiles":"C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O","inchiKey":"BHJIBOFHEFDSAU-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RALFINAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FCE-26742A","Nw-1029","PNU-0154339E","Priralfinamide","Ralfinamide"],"crossReferences":{"drugbank":["DB06649"]},"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000116032","ENSG00000136546","ENSG00000069535","ENSG00000148408","ENSG00000198785","ENSG00000168356","ENSG00000007314","ENSG00000196876","ENSG00000185313","ENSG00000161509","ENSG00000183873","ENSG00000144285","ENSG00000105464","ENSG00000169432","ENSG00000176884","ENSG00000136531","ENSG00000153253"],"count":19},"linkedDiseases":{"rows":["EFO_0005762","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107861","drugType":"Antibody","blackBoxWarning":false,"name":"ZALUTUMUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2F8","HUMAX-EGFR, 2F8","HUMAX-EGFR-2F8","HuMax-EGFr","Zalutumumab"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0006859","EFO_0004284","EFO_0000707","EFO_0003060","EFO_1001951"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108046","drugType":"Cell","blackBoxWarning":false,"name":"REMESTEMCEL-L","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Prochymal"],"synonyms":["JR-0301","Remestemcel","Remestemcel-l"],"description":"Cell drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2108354","drugType":"Antibody","blackBoxWarning":false,"name":"UBLITUXIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TG-1101","Ublituximab"],"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","EFO_0000096","MONDO_0005301","EFO_0000095","EFO_0000403","EFO_0004256","EFO_0003929","MONDO_0018906","EFO_1001469"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2108592","drugType":"Antibody","blackBoxWarning":false,"name":"EPITUMOMAB CITUXETAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epitumomab cituxetan","Hmfg 1"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108725","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"ANIVAMERSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anivamersen","RB-007","RB007"],"description":"Oligonucleotide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2152922","canonicalSmiles":"OC1(CN2CCC(COc3noc4cccc(O[C@@H]5CCOC5)c34)CC2)CCOCC1","inchiKey":"WLLOFQROROXOMO-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04995274","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-04995274"],"crossReferences":{"drugbank":["DB12675"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2177913","canonicalSmiles":"NC1=N[C@@](c2cccc(-c3cncnc3)c2)(c2ccnc(C(F)F)c2)c2cccc(F)c21","inchiKey":"MRXBCEQZNKUUIP-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-3839","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD3839","Azd 3839","Azd-3839","Azd3839"],"crossReferences":{"drugbank":["DB12368"]},"childChemblIds":["CHEMBL3542290","CHEMBL3542259"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2178953","canonicalSmiles":"Cc1nc(C)c(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)nc1C(N)=O","inchiKey":"YXFNPRHZMOGREC-SHTZXODSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2178953","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14949"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL218394","canonicalSmiles":"CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C","inchiKey":"LHHCSNFAOIFYRV-DOVBMPENSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BOCEPREVIR","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Victrelis"],"synonyms":["Boceprevir","EBP 520","EBP-520","SCH 503034","SCH-503034"],"crossReferences":{"Wikipedia":["Boceprevir"],"drugbank":["DB08873"],"chEBI":["68621"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for chronic hepatitis c virus infection and viral disease and has 2 investigational indications."}
{"id":"CHEMBL237500","canonicalSmiles":"CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C","inchiKey":"LTXREWYXXSTFRX-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINAGLIPTIN","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tradjenta","Trajenta"],"synonyms":["BI 1356","BI 1356 BS","BI-1356","BI-1356-BS","BI-1356BS","BS 1356 BS","BS-1356-BS","Linagliptin","Trazenta"],"crossReferences":{"DailyMed":["linagliptin"],"Wikipedia":["Linagliptin"],"drugbank":["DB08882"],"chEBI":["68610"]},"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["HP_0000083","MONDO_0005090","MONDO_0100096","EFO_0002916","EFO_0000684","EFO_0000503","EFO_0004997","MONDO_0003219","MONDO_0005148","EFO_0000400","EFO_0003060","EFO_0000660","EFO_0000537"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for diabetes mellitus and type 2 diabetes mellitus and has 8 investigational indications."}
{"id":"CHEMBL2393130","canonicalSmiles":"COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1","inchiKey":"NETXMUIMUZJUTB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APABETALONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apabetalone","RVX-000222","RVX-208","RVX000222"],"crossReferences":{"drugbank":["DB12000"]},"linkedTargets":{"rows":["ENSG00000169925","ENSG00000204256","ENSG00000137948","ENSG00000141867"],"count":4},"linkedDiseases":{"rows":["EFO_0001361","MONDO_0100096","EFO_0001645","EFO_0003884","Orphanet_324","EFO_0000400"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL252967","canonicalSmiles":"CCCn1c(C2CCN(C)CC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CC2)n1","inchiKey":"XCTKFTOEAKJMII-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL252967","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03084"],"chEBI":["47188"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL253376","canonicalSmiles":"CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1","inchiKey":"OJGDCBLYJGHCIH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMHEXINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bromhexine","Fluibron"],"crossReferences":{"PubChem":["174006813"],"Wikipedia":["Bromhexine"],"drugbank":["DB09019"],"chEBI":["77032"]},"childChemblIds":["CHEMBL1319139"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL274323","canonicalSmiles":"N[C@@H](CC(=O)O)C(=O)O","inchiKey":"CKLJMWTZIZZHCS-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASPARTIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aspartate","Aspartic acid","Aspartic acid, l-","Aspartic acid,l","Deamidated asparagine","FEMA NO. 3656","L-aspartic acid","NSC-3973"],"crossReferences":{"PubChem":["11113409","26751648","50104339","90340967"],"drugbank":["DB00128"],"chEBI":["17053"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL28885","canonicalSmiles":"N[C@@H](COS(=O)(=O)O)C(=O)O","inchiKey":"LFZGUGJDVUUGLK-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-Serine O-Sulfate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-Serine O-Sulfate","Serine O-Sulfate"],"crossReferences":{"drugbank":["DB03497"],"chEBI":["15829"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL290194","canonicalSmiles":"C=CCN1CCCC1CNC(=O)c1cc2nn[nH]c2cc1OC","inchiKey":"KSEYRUGYKHXGFW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALIZAPRIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alizapride","Litican","Plitican","Superan","Vergentan"],"crossReferences":{"Wikipedia":["Alizapride"],"drugbank":["DB01425"]},"childChemblIds":["CHEMBL1896987"],"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL29741","canonicalSmiles":"CN(C)CCOc1ccccc1-c1nc(-c2ccccc2)no1","inchiKey":"QZULPCPLWGCGSL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IRAMPANEL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIR 561","BIIR-561","BIIR-561 CL","Irampanel"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL29898","canonicalSmiles":"O=C1c2ccc(O)c(O)c2C(=O)c2c(O)ccc(O)c21","inchiKey":"VBHKTXLEJZIDJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINALIZARIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,2,5,8-Tetrahydroxy-Anthraquinone","Quinalizarin"],"crossReferences":{"PubChem":["26749241","538929"],"Wikipedia":["Quinalizarin"],"drugbank":["DB08660"],"chEBI":["37495"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3182532","canonicalSmiles":"CCCCCCOc1cc(C)c(O)c(C)c1C","inchiKey":"ATMNQRRJNBCQJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HX-1171","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hexyloxy trimethylphenol","Hx-1171"],"crossReferences":{"PubChem":["144211562"],"drugbank":["DB12162"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL326564","canonicalSmiles":"CCCCn1c(Cc2ccc3c(c2)OCO3)nc2c(N)ncnc21","inchiKey":"JCDXXNIRWRRGBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL326564","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08436"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301600","canonicalSmiles":"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1.O=S(=O)(O)c1ccccc1","inchiKey":"ABSXPNGWJFAPRT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPEBRUTINIB BESYLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3301625","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVL-292","AVL-292 BESYLATE","CC-292","CC-292 BESYLATE","Spebrutinib","Spebrutinib besilate","Spebrutinib besylate"],"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000685","EFO_0000403"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3301626","canonicalSmiles":"Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(F)cc1","inchiKey":"UPZWINBEAHDTLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BASIMGLURANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Basimglurant","NOE-101","RG-7090","RO-4917523","RO4917523","Rg7090"],"crossReferences":{"drugbank":["DB11833"]},"linkedTargets":{"rows":["ENSG00000168959"],"count":1},"linkedDiseases":{"rows":["EFO_1001219","MONDO_0002050","MONDO_0002009","Orphanet_805","Orphanet_908"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL334491","canonicalSmiles":"CC(C)(C)N1CCC(c2ccccc2)(c2ccccc2)CC1","inchiKey":"QIHLUZAFSSMXHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUDIPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Budipine"],"crossReferences":{"Wikipedia":["Budipine"],"drugbank":["DB13502"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL33986","canonicalSmiles":"Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3","inchiKey":"IFKLAQQSCNILHL-QHAWAJNXSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUTORPHANOL","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Butorphanol","LEVO-BC-2627"],"crossReferences":{"DailyMed":["butorphanol%20tartrate"],"Wikipedia":["Butorphanol"],"chEBI":["3242"]},"childChemblIds":["CHEMBL299400"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000112038"],"count":2},"linkedDiseases":{"rows":["EFO_0003890","HP_0002093","EFO_0005230","EFO_0003843"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for pain and drug dependence and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3545079","drugType":"Small molecule","blackBoxWarning":false,"name":"PLX-5622","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PLX-5622","PLX5622","Plx-5622"],"linkedTargets":{"rows":["ENSG00000182578"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3639788","canonicalSmiles":"O=C(Cc1cccc(OC(F)(F)F)c1)Nc1ccc(CCCCc2nnc(NC(=O)Cc3ccccn3)s2)nn1","inchiKey":"PRAAPINBUWJLGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELAGLENASTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CB-839","Telaglenastat"],"crossReferences":{"drugbank":["DB15232"]},"childChemblIds":["CHEMBL4594286"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL3707210","name":"CHEMBL3707210","tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11342"]}}
{"id":"CHEMBL3707234","canonicalSmiles":"O=C(NC(Cc1ccccc1)c1ccccc1)c1cccnc1","inchiKey":"DWODOIKZDGJOPQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOFETAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C 1065","C-1065","Lispamina","Lyspamin","Nicofetamide"],"crossReferences":{"drugbank":["DB13531"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3833306","drugType":"Antibody","blackBoxWarning":false,"name":"VANDORTUZUMAB VEDOTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DSTP3086S","MSTP2109A","RG-7450","RG7450","Vandortuzumab vedotin"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000164647","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["MONDO_0008315"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL383923","canonicalSmiles":"O=c1cc(O)n([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"UDOBICLZEKUKCV-YXZULKJRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"6-hydroxy-UMP","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["6-hydroxy-UMP"],"crossReferences":{"drugbank":["DB02890"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL395280","canonicalSmiles":"C/C=C1\\[C@H]2C=C(C)C[C@]1(N)c1ccc(=O)[nH]c1C2","inchiKey":"ZRJBHWIHUMBLCN-YQEJDHNASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL395280","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205156","170466837"],"Wikipedia":["Huperzine_A"],"drugbank":["DB04864"],"chEBI":["78330"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989826","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314.COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314.O=C(O)c1ccc(C(=O)O)cc1","inchiKey":"BTEYIHUKHHAVAN-KDKWOIFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYCODONE TEREPHTHALATE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL656","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Oxycodone terephthalate"],"crossReferences":{"DailyMed":["oxycodone%20terephthalate"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1950 and is indicated for pain."}
{"id":"CHEMBL3989856","canonicalSmiles":"O.O.O.O.O.O.O.O.O.O.O=S(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"RSIJVJUOQBWMIM-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM SULFATE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL233406","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glaubers Salt","Golytely"],"synonyms":["Glauber's salt","Glaubers salt (decahydrate from)","Mang xiao","Mangxiao","Natrii sulfas","Natrum sulphuricum","Sodium sulfate","Sodium sulfate anhydrous","Sodium sulfate, dried"],"crossReferences":{"DailyMed":["sodium%20sulfate","sodium%20sulfate%20anhydrous"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984 and is indicated for constipation."}
{"id":"CHEMBL4070364","canonicalSmiles":"CNC(C)C(=O)c1ccccc1","inchiKey":"LPLLVINFLBSFRP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4070364","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15339"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL418971","canonicalSmiles":"CC(C)(c1ccc(O)cc1)c1ccc(O)cc1","inchiKey":"IISBACLAFKSPIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BISPHENOL A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124890224","144210190","144214049","17389142","17390010","26752849","49718108","92277586"],"Wikipedia":["Bisphenol_A"],"drugbank":["DB06973"],"chEBI":["33216"]},"childChemblIds":["CHEMBL4790947"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297363","canonicalSmiles":"CCOC(=O)[C@H](Cc1ccc(Nc2nccc3ccncc23)cc1)NC1=C(Br)C(=O)C12CCCCC2","inchiKey":"QCYAXXZCQKMTMO-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UCB-1184197","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDP-323","CDP323","Cdp323","Ucb-1184197","Zaurategrast ethyl ester"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297434","canonicalSmiles":"CC(C)(CS(=O)(=O)[O-])N(Cl)Cl.O.[Na+]","inchiKey":"DZYCRLINOCERBD-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"AURICLOSENE MONOSODIUM MONOHYDRATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1207907","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-46383A","Auriclosene monosodium monohydrate","Nvc-422 monosodium monohydrate","Sodium 2-(dichloroamino)-2-methylpropane-1-sulfonate monohydrate"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297648","canonicalSmiles":"[O-][n+]1cccc(-c2nc3c(Cl)cccc3cc2[C@@H](Nc2ncnc3cccnc23)C(F)(F)F)c1","inchiKey":"LNLJHGXOFYUARS-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELETALISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Seletalisib","UCB-5857","UCB5857","Ucb5857"],"crossReferences":{"drugbank":["DB12706"]},"linkedTargets":{"rows":["ENSG00000171608"],"count":1},"linkedDiseases":{"rows":["EFO_0000676","EFO_0000699"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297657","canonicalSmiles":"CC(=O)O.CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2","inchiKey":"HZHXFIDENGBQFQ-FTBISJDPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDACATEROL ACETATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1095777","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Indacaterol acetate"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297693","drugType":"Unknown","blackBoxWarning":false,"name":"AMP-110","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMP-110","Amp-110"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297864","drugType":"Antibody","blackBoxWarning":false,"name":"CENDAKIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-308","Abt-308","CC-93538","Cendakimab","RPC-4046"],"linkedTargets":{"rows":["ENSG00000169194"],"count":1},"linkedDiseases":{"rows":["EFO_0004232","EFO_1001463","MONDO_0004979"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297910","drugType":"Unknown","blackBoxWarning":false,"name":"ARTEMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Artemin","BG-00010","BG00010","Bg00010","Enovin","Neublastin"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298105","drugType":"Protein","blackBoxWarning":false,"name":"VALZIFLOCEPT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SHP-652","SHP652","SM-101","SM101","Sm101","Valziflocept"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL453716","canonicalSmiles":"C1COCCO1","inchiKey":"RYHBNJHYFVUHQT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIOXANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,4-Dioxane"],"crossReferences":{"PubChem":["144208169"],"Wikipedia":["1,4-Dioxane"],"drugbank":["DB03316"],"chEBI":["47032"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL456218","canonicalSmiles":"COc1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1F","inchiKey":"TUTZKAQTSPMEBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL456218","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07014"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL459008","canonicalSmiles":"CCCCOC(=O)c1ccc(O)cc1","inchiKey":"QFOHBWFCKVYLES-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTYLPARABEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butyl p-hydroxy benzoate","Butyl p-hydroxybenzoate","Butyl paraben","Butyl parahydroxybenzoate","Butylparaben","FEMA NO. 2203","NSC-13164"],"crossReferences":{"PubChem":["104171292","11112246","144203944","144208983","144210650","170465688","17390002","22405509","26752916"],"Wikipedia":["Butylparaben"],"drugbank":["DB14084"],"chEBI":["88542"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594367","drugType":"Unknown","blackBoxWarning":false,"name":"AK-01","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AK-01","Ak-01","LY-3295668","LY3295668","Ly3295668"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594407","canonicalSmiles":"CCCCCCCCC=CCCCCCCCC(=O)OCC1COP(=O)(O)C1","inchiKey":"PUPWWTUVIZOPTB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBACYCLIC PHOSPHATIDIC ACID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2ccpa","Carbacyclic phosphatidic acid"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL460","canonicalSmiles":"CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2","inchiKey":"KLPWJLBORRMFGK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MOLINDONE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Moban","Molindone","Spn-810"],"crossReferences":{"DailyMed":["molindone%20hydrochloride"],"PubChem":["26755691","50111112","90341242"],"Wikipedia":["Molindone"],"drugbank":["DB01618"],"chEBI":["6965"]},"childChemblIds":["CHEMBL1200419"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["EFO_0003888","MONDO_0005090","EFO_0005407"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for psychosis and schizophrenia and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4650287","drugType":"Cell","blackBoxWarning":false,"name":"SNK01","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SNK01","Snk01"],"description":"Cell drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650314","canonicalSmiles":"O=C(O)CNC(=O)c1c(O)c2ccccc2n(OCC2CC2)c1=O","inchiKey":"IKRKQQLJYBAPQT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESIDUSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Desidustat","ZYAN1","Zyan-1"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4650316","canonicalSmiles":"C[C@@H]1Cc2c([nH]c3ccccc23)[C@@H](c2c(F)cc(NC3CN(CCCF)C3)cc2F)N1CC(F)(F)CO","inchiKey":"GQCXHIKRWBIQMD-AKJBCIBTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GIREDESTRANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-9545","Gdc-9545","Giredestrant","RO-7197597","RO7197597"],"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL468154","canonicalSmiles":"O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"CDAISMWEOUEBRE-CDRYSYESSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SCYLLITOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-103","Cocositol","Cyclohexane-1,2,3,4,5,6-Hexaol","ELND-005","ELND005","Inositol, scyllo-","Quercinitol","Scyllitol","Scyllo-cyclohexanehexol","Scyllo-inositol"],"crossReferences":{"drugbank":["DB03106"],"chEBI":["10642"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4802186","drugType":"Unknown","blackBoxWarning":false,"name":"ZN-C3","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ZN-C3","Zn-c3"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL481611","canonicalSmiles":"CC(C)(F)C[C@H](N[C@@H](c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1","inchiKey":"FWIVDMJALNEADT-SFTDATJTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ODANACATIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0822","MK0822","Odanacatib"],"crossReferences":{"Wikipedia":["Odanacatib"],"drugbank":["DB06670"]},"linkedTargets":{"rows":["ENSG00000143387"],"count":1},"linkedDiseases":{"rows":["HP_0000083","EFO_0003854","MONDO_0007254","EFO_0003882","MONDO_0005178","MONDO_0008315"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL484726","canonicalSmiles":"Cc1c(/N=C2\\O[C@@H](C(F)(F)F)[C@@H]3[C@@H](O)CCN23)ccc(C#N)c1Cl","inchiKey":"KALFKWQLCWAXJO-RNSKTZJQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL484726","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08088"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL50267","canonicalSmiles":"O=C(O)c1cc(O)c2c(Cl)cc(Cl)cc2n1","inchiKey":"BGKFPRIGXAVYNX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5,7-Dichlorokynurenic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5,7-Dichlorokynurenic Acid"],"crossReferences":{"PubChem":["11111036","11113436","124879827","26747105","26751671","50104367","90341603"],"drugbank":["DB01931"]},"childChemblIds":["CHEMBL1731625"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL549473","canonicalSmiles":"[O-][n+]1ccccc1SSc1cccc[n+]1[O-]","inchiKey":"ZHDBTKPXEJDTTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPYRITHIONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bispyrithione","Dipyrithione","NSC-241716","NSC-84740","OMDS","Omadine disulfide","Pyrithione disulfide","Pyrithione disulphide"],"crossReferences":{"PubChem":["144205684","170465699","26757912"],"drugbank":["DB11327"]},"childChemblIds":["CHEMBL2106674"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL550936","canonicalSmiles":"CC(C)C(=O)OC[C@@]1(N=[N+]=[N-])O[C@@H](n2ccc(N)nc2=O)[C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C","inchiKey":"VKXWOLCNTHXCLF-DXEZIKHYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BALAPIRAVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Balapiravir","RO-4588161","RO4588161"],"crossReferences":{"drugbank":["DB12283"]},"childChemblIds":["CHEMBL2105678"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL550961","canonicalSmiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/CN1C(=O)c2cccc(O)c2Nc2c(O)cc(O)cc21","inchiKey":"SALVHVNECODMJP-GNUCVDFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIAZEPINOMICIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amo-01","BU-4664L","Diazepinomicin","ECO-4601","TLN-4601"],"crossReferences":{"drugbank":["DB12420"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL573819","canonicalSmiles":"O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl","inchiKey":"FCADPEDUULETPK-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL573819","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07046"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL590753","canonicalSmiles":"Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CC2CC2)n1","inchiKey":"DFEYXQGDDCDXJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-218655","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SB-218655"],"crossReferences":{"drugbank":["DB03980"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL592868","canonicalSmiles":"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C","inchiKey":"GJUHUIXJLZINMA-MJCUULBUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESTROGEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Estrogen"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL886","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)cc1F","inchiKey":"HFEKDTCAMMOLQP-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5-FLUORODEOXYURIDYLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Fluoro-2-Deoxyuridine Monophosphate (Fdump)"],"crossReferences":{"drugbank":["DB03761"],"chEBI":["2129"]},"childChemblIds":["CHEMBL1823492"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL925","canonicalSmiles":"N[C@@H](Cc1ccc(O)cc1)C(=O)O","inchiKey":"OUYCCCASQSFEME-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TYROSINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["FEMA NO. 3736","L-tyrosine","Levodopa impurity, l-tyrosine-","Levodopa related compound l-tyrosine","NSC-82624","Tyrosine"],"crossReferences":{"PubChem":["144205147","170466853","29215265"],"Wikipedia":["Tyrosine"],"drugbank":["DB00135"],"chEBI":["17895"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for type 2 diabetes mellitus and has 2 investigational indications."}
{"id":"CHEMBL956","canonicalSmiles":"CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1","inchiKey":"MDKGKXOCJGEUJW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUPROFEN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," United Kingdom"," Spain"],"classes":["Musculoskeletal toxicity"," Nephrotoxicity"],"year":1987},"tradeNames":["Profenal"],"synonyms":["NSC-303611","P-(2-thenoyl)hydratropic acid","P-2-thenoylhydratropic acid","R-25,061","R-25061","Racemic suprofen","Srendam","Sulproltin","Suprofen","Sutoprofen","TN-762","Topalgic"],"crossReferences":{"PubChem":["144204194","170465412","26748525","56463227"],"Wikipedia":["Suprofen"],"drugbank":["DB00870"],"chEBI":["9362"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0005755"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985 and is indicated for rheumatic disease. It was withdrawn in United States,  United Kingdom and  Spain initially in 1987 due to Musculoskeletal toxicity and  Nephrotoxicity."}
{"id":"CHEMBL971","canonicalSmiles":"CCCC(C)C1(CC)C(=O)[N-]C(=O)NC1=O.[Na+]","inchiKey":"QGMRQYFBGABWDR-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTOBARBITAL SODIUM","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL448","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Norway"],"classes":["Misuse"],"year":1980},"tradeNames":["Beuthanasia","Euthanase","Euthatal","Nembutal","Nembutal sodium","Pentobarbital sodium","Pentobarbitone Sodium","Sagatal","Sodium pentobarbital"],"synonyms":["Auropan","Barpental","Biosedan","Diabutal","Embutal","Entobar","Etaminal sodium","Ethaminal sodium","Euthanyl","Euthatal","Isobarb","Mebubarbital sodium","Mebumal sodium","NSC-10816","Napental","Narcoren","Pacifan","Pental","Pentobarbital sodium","Pentobarbital sodium salt","Pentobarbitone sodium","Pentonal","Pentone","Praecicalm","Rs-pentobarbital sodium","Sagatal","Sodium ethaminal","Sodium nembutal","Sodium pental","Sodium pentobarbitone","Sodium pentobarbiturate","Sodium-pent","Soluble pentobarbital","Somnopentyl","Somnotol","Sopental","Sotyl","V-pento","Vetbutal"],"crossReferences":{"DailyMed":["pentobarbital%20sodium"],"chEBI":["7984"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1973. It was withdrawn in Norway  in 1980 due to Misuse."}
